The UroOnc Minute: Neoadjuvant Therapy Before Radical Prostatectomy, With Isaac Y. Kim, MD, PhD, MBA
Isaac Y. Kim, MD, PhD, MBA, joins to discuss the evolving data surrounding neoadjuvant therapy before radical prostatectomy in prostate cancer.
Isaac Y. Kim, MD, PhD, MBA
Advertisement
Articles by Isaac Y. Kim, MD, PhD, MBA
In this video, Isaac Y. Kim, MD, PhD, MBA, discusses why immunotherapy may ultimately represent the next major advance in prostate cancer treatment.
Isaac Y. Kim, MD, PhD, MBA, reflects on concerning trends in prostate cancer mortality, emphasizing how advances in diagnostics, treatment, and artificial intelligence may improve outcomes in the future.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants RMAT designation to EG110A for neurogenic detrusor overactivity
2
PSMA-PET in clinical practice: Juan Gómez Rivas, MD, on barriers to access
3
FAQs: The 2026 AUA Guideline on Medical Management of Kidney Stones
4
CHMP recommends perioperative enfortumab vedotin plus pembrolizumab for MIBC
5